Related Experiment Video
Updated: Jan 19, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile
Isaac L Goldenthal1, Robert R Sciacca2, Teresa Riga1
1Department of Medicine - Cardiology, Columbia University Irving Medical Center, New York, New York.
Insights
Daily mobile electrocardiogram (ECG) self-recordings led to earlier detection of atrial fibrillation (AF) or atrial flutter (AFL) recurrence after treatment. This approach may also empower patients in shared decision-making for arrhythmia management.
Area of Science:
- Cardiology
- Digital Health
- Medical Devices
Background:
- Atrial fibrillation (AF) and atrial flutter (AFL) have high recurrence rates after treatment (20-45% for RFA, 60-80% for DCCV).
- Limited randomized trials exist comparing mobile ECG devices to standard care for post-treatment AF/AFL monitoring.
Purpose of the Study:
- To evaluate the impact of daily ECG self-recordings on the time to documented recurrent AF/AFL.
- To assess the effect on time to treatment for recurrent arrhythmias in patients post-catheter radiofrequency ablation (RFA) or direct current cardioversion (DCCV).
Main Methods:
- 238 patients were randomized to standard care or the iHEART intervention (daily mobile ECG recordings).
- Intervention group used AliveCor KardiaMobile ECG devices for daily self-recording and transmission.
- Data collected from ECGs and electronic health records.
Main Results:
- The intervention group showed a greater likelihood of recurrence detection (HR=1.56, P=0.024).
- Early recurrence (within the first month) strongly predicted later recurrence (HR=4.53, P=0.0006).
- Time from detection to treatment was shorter in the control group (HR=0.33, P<0.0001).
Conclusions:
- Mobile ECG self-recording facilitates earlier detection of AF/AFL recurrence.
- This technology can empower patients in shared health decision-making regarding their arrhythmia management.
Objective:
This study evaluated the impact of daily ECG (electrocardiogram) self-recordings on time to documented recurrent atrial fibrillation (AF) or atrial flutter (AFL) and time to treatment of recurrent arrhythmia in patients undergoing catheter radiofrequency ablation (RFA) or direct current cardioversion (DCCV) for AF/AFL.
Background:
AF recurrence rates after RFA and DCCV are 20% to 45% and 60% to 80%, respectively. Randomized trials comparing mobile ECG devices to standard of care have not been performed in an AF/AFL population after treatment.
Methods:
Of 262 patients consented, 238 were randomized to either standard of care (123) or to receive the iHEART intervention (115). Patients in the intervention group were provided with and trained to use an AliveCor KardiaMobile ECG monitor, and were instructed to take and transmit daily ECG recordings. Data were collected from transmitted ECG recordings and patients' electronic health records.
Results:
In a multivariate Cox model, the likelihood of recurrence detection was greater in the intervention group (hazard ratio = 1.56, 95% confidence interval [CI]: 1.06-2.30, P = .024). Hazard ratios did not differ significantly for RFA and DCCV procedures. Recurrence during the first month after ablation strongly predicted later recurrence (hazard ratio = 4.53, 95% CI: 2.05-10.00, P = .0006). Time from detection to treatment was shorter for the control group (hazard ratio = 0.33, 95% CI: 0.57-2.92, P < .0001).
Conclusions:
The use of mobile ECG self-recording devices allows for earlier detection of AF/AFL recurrence and may empower patients to engage in shared health decision-making.
More Related Videos
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
04:58Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
Published on: August 25, 2022
Related Concept Videos
11:21Robotic Ablation of Atrial Fibrillation
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
04:58Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation
05:12Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:43Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation